NDC 55111-763-07 - Montelukast Sodium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 55111-763
- Requested NDC
- 55111-763-07
- Package NDCs from labels
- 55111-763-07, 55111-763-03
- Manufacturer
- Dr.Reddy's Laboratories Limited | Dr.Reddy's Laboratories Limited-FTO3
- Effective date
- 2019-08-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Montelukast Sodium - Dr.Reddy's Laboratories Limited | Dr.Reddy's Laboratories Limited-FTO3 | Dr.Reddy's Laboratories Limited | Dr.Reddy's Laboratories Limited-FTO3 | 2019-08-30 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 55111-763-03 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-5f2d-d83d-e063-dadaa90ab31f | These highlights do not include all the information needed to use MONTELUKAST SODIUM ORAL GRANULES safely and effectively. See full prescribing information for MONTELUKAST SODIUM ORAL GRANULES . MONTELUKAST SODIUM oral granules, for oral use Initial U.S. Approval: 1998 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 55111-763-03 | Montelukast Sodium | 30 in 1 CARTON | GRANULE | 30 | 15 | |
| 55111-763-07 | Montelukast Sodium | 500 in 1 PACKET | GRANULE | 500 | 15 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 55111-763-03 | EA - Each | 55111-763 | 569ceb14-5889-4aeb-804d-5c1cac519e04 | 1 | 2013-02-13 |
| 55111-763-07 | EA - Each | 55111-763 | ef749b31-25f5-4d9c-a7e2-3dadf931d5bf | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Montelukast Sodium | ACTIVE INGREDIENT | U1O3J18SFL | MONTELUKAST SODIUM GRANULE [DR.REDDY'S LABORATORIES LIMITED] | 12 | |
| montelukast | ACTIVE MOIETY | MHM278SD3E | MONTELUKAST SODIUM GRANULE [DR.REDDY'S LABORATORIES LIMITED] | 12 | |
| HYPROMELLOSE 2910 (3 MPA.S) | INACTIVE INGREDIENT | 0VUT3PMY82 | MONTELUKAST SODIUM GRANULE [DR.REDDY'S LABORATORIES LIMITED] | 12 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | MONTELUKAST SODIUM GRANULE [DR.REDDY'S LABORATORIES LIMITED] | 12 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | MONTELUKAST SODIUM GRANULE [DR.REDDY'S LABORATORIES LIMITED] | 12 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Montelukast Sodium | MONTELUKAST SODIUM | PD-Rx Pharmaceuticals, Inc. | 6ffff72c-8784-477b-8722-5434a19881a0 | 2025-10-09 | Boxed warning, Warnings, Adverse reactions | U1O3J18SFL |
| MONTELUKAST SODIUM | MONTELUKAST SODIUM | Ajanta Pharma USA Inc. | 67070e4e-f755-46b3-b900-fcc1993a0546 | 2025-08-29 | Boxed warning, Warnings, Adverse reactions | 351246 U1O3J18SFL |
| Osmitrol | MANNITOL | Baxter Healthcare Company | 0d914965-7001-45cb-ba51-d7c5964b05bc | 2025-08-26 | Warnings, Adverse reactions | 3OWL53L36A |
| Montelukast Sodium | MONTELUKAST SODIUM | Major Pharmaceuticals | a4dc63cf-8145-42f4-9437-93b414d2aed4 | 2025-06-19 | Boxed warning, Warnings, Adverse reactions | U1O3J18SFL |
| Montelukast | MONTELUKAST | Sandoz Inc | 6d69e73a-76cb-4ece-9cf9-e9adb4f523b4 | 2025-06-13 | Boxed warning, Warnings, Adverse reactions | U1O3J18SFL |
| Montelukast | MONTELUKAST | NuCare Pharmaceuticals, Inc. | 365e1c5c-01b2-bf4e-e063-6394a90a0e43 | 2025-05-30 | Boxed warning, Warnings, Adverse reactions | U1O3J18SFL |
| Mannitol | MANNITOL | Henry Schein, Inc. | e2444db1-9dfe-451f-a33c-9b00786464d2 | 2025-05-20 | Warnings, Adverse reactions | 3OWL53L36A |
| SINGULAIR | MONTELUKAST SODIUM | Organon LLC | 482dcc92-b47f-4ea6-854a-f5ac2aea7842 | 2025-04-30 | Boxed warning, Warnings, Adverse reactions | 351246 U1O3J18SFL |
| Montelukast Sodium | MONTELUKAST | Amneal Pharmaceuticals LLC | bcd49102-a21c-4628-a322-6cdd934e7f09 | 2025-04-18 | Boxed warning, Warnings, Adverse reactions | U1O3J18SFL |
| MONTELUKAST SODIUM | MONTELUKAST SODIUM | Camber Pharmaceuticals, Inc. | 97a682c2-7e00-4d07-a5ac-4436c977f842 | 2025-03-13 | Boxed warning, Warnings, Adverse reactions | U1O3J18SFL |
| Montelukast | MONTELUKAST | Quallent Pharmaceuticals Health LLC | 5d71088b-b0fa-4bf0-a6e7-6163bd9e0dd4 | 2025-02-28 | Boxed warning, Warnings, Adverse reactions | U1O3J18SFL |
| MONTELUKAST SODIUM | MONTELUKAST SODIUM | Direct_Rx | f3bdf2a3-d661-5128-e053-2995a90a4661 | 2025-01-22 | Boxed warning, Warnings, Adverse reactions | U1O3J18SFL |
| montelukast sodium | MONTELUKAST SODIUM | NuCare Pharmaceuticals,Inc. | a7c11cbe-0834-27a5-e053-2995a90ac43f | 2024-12-30 | Boxed warning, Warnings, Adverse reactions | U1O3J18SFL |
| Montelukast Sodium | MONTELUKAST SODIUM | American Health Packaging | fb1b2e4e-a840-447b-b943-ad0b6acc32b5 | 2024-10-31 | Boxed warning, Warnings, Adverse reactions | U1O3J18SFL |
| montelukast sodium | MONTELUKAST SODIUM | Bryant Ranch Prepack | 3ff4100f-11e3-4d6a-ab88-83bd605a1818 | 2024-10-07 | Boxed warning, Warnings, Adverse reactions | U1O3J18SFL |
| Montelukast | MONTELUKAST | Bryant Ranch Prepack | 6b26218d-52a6-4109-90e4-412a17d14fcf | 2024-08-08 | Boxed warning, Warnings, Adverse reactions | U1O3J18SFL |
| MONTELUKAST SODIUM | MONTELUKAST SODIUM | Rising Pharma Holdings, Inc. | 75723c5a-3c9e-468a-bc65-57b4c755889a | 2024-07-26 | Boxed warning, Warnings, Adverse reactions | U1O3J18SFL |
| Montelukast Sodium | MONTELUKAST SODIUM | NuCare Pharmaceuticals,Inc. | 566a8fd7-fc00-2297-e054-00144ff8d46c | 2024-07-17 | Warnings, Adverse reactions | U1O3J18SFL |
| Montelukast | MONTELUKAST | NuCare Pharmaceuticals,Inc. | 56429f04-97b6-06a9-e054-00144ff88e88 | 2024-07-17 | Warnings, Adverse reactions | U1O3J18SFL |
| Montelukast Sodium | MONTELUKAST SODIUM | NuCare Pharmaceuticals,Inc. | 549f1d1a-81f5-29f5-e054-00144ff8d46c | 2024-07-10 | Warnings, Adverse reactions | U1O3J18SFL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.